1.
Diabetes Res Clin Pract
; 213: 111740, 2024 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38852625
RESUMO
There have been shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RA) for type 2 diabetes (T2D) care. Analyses of data from 811 T2D adults at an Australian specialist diabetes clinic (1/2019-10/2023) who received ≥ 2 GLP-1 RA prescriptions before and during the shortage showed median HbA1c levels significantly increased by 0.3 %.